Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group.
Am J Respir Crit Care Med. 1999 Dec;160(6):1862-8. doi: 10.1164/ajrccm.160.6.9803042.
Am J Respir Crit Care Med. 1999.
PMID: 10588598
Clinical Trial.
Effect of montelukast on single-dose theophylline pharmacokinetics.
Malmstrom K, Schwartz J, Reiss TF, Sullivan TJ, Reese JH, Jauregui L, Miller K, Scott M, Shingo S, Peszek I, Larson P, Ebel D, Hunt TL, Huhn RD, Bachmann K.
Malmstrom K, et al. Among authors: peszek i.
Am J Ther. 1998 May;5(3):189-95. doi: 10.1097/00045391-199805000-00010.
Am J Ther. 1998.
PMID: 10099058
Clinical Trial.
Item in Clipboard
Quality assurance of asthma clinical trials.
Malmstrom K, Peszek I, Al Botto, Lu S, Enright PL, Reiss TF.
Malmstrom K, et al. Among authors: peszek i.
Control Clin Trials. 2002 Apr;23(2):143-56. doi: 10.1016/s0197-2456(01)00197-0.
Control Clin Trials. 2002.
PMID: 11943441
Clinical Trial.
Item in Clipboard
Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma.
Reicin A, White R, Weinstein SF, Finn AF Jr, Nguyen H, Peszek I, Geissler L, Seidenberg BC.
Reicin A, et al. Among authors: peszek i.
Arch Intern Med. 2000 Sep 11;160(16):2481-8. doi: 10.1001/archinte.160.16.2481.
Arch Intern Med. 2000.
PMID: 10979060
Clinical Trial.
Item in Clipboard
The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma.
Diamant Z, Grootendorst DC, Veselic-Charvat M, Timmers MC, De Smet M, Leff JA, Seidenberg BC, Zwinderman AH, Peszek I, Sterk PJ.
Diamant Z, et al. Among authors: peszek i.
Clin Exp Allergy. 1999 Jan;29(1):42-51. doi: 10.1046/j.1365-2222.1999.00447.x.
Clin Exp Allergy. 1999.
PMID: 10051701
Clinical Trial.
Item in Clipboard
Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial.
Herman GA, O'Brien MP, Forleo-Neto E, Sarkar N, Isa F, Hou P, Chan KC, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Musser BJ, Davis JD, Turner KC, Mahmood A, Hooper AT, Hamilton JD, Parrino J, Subramaniam D, Baum A, Kyratsous CA, DiCioccio AT, Stahl N, Braunstein N, Yancopoulos GD, Weinreich DM; COVID-19 Phase 3 Prevention Trial Team.
Herman GA, et al.
Lancet Infect Dis. 2022 Oct;22(10):1444-1454. doi: 10.1016/S1473-3099(22)00416-9. Epub 2022 Jul 5.
Lancet Infect Dis. 2022.
PMID: 35803290
Free PMC article.
Clinical Trial.
Item in Clipboard
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
O'Brien MP, Forleo-Neto E, Sarkar N, Isa F, Hou P, Chan KC, Musser BJ, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Brown ER, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Geba GP, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM; COVID-19 Phase 3 Prevention Trial Team.
O'Brien MP, et al.
JAMA. 2022 Feb 1;327(5):432-441. doi: 10.1001/jama.2021.24939.
JAMA. 2022.
PMID: 35029629
Free PMC article.
Clinical Trial.
Item in Clipboard
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
O'Brien MP, Forleo-Neto E, Musser BJ, Isa F, Chan KC, Sarkar N, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Hou P, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM; Covid-19 Phase 3 Prevention Trial Team.
O'Brien MP, et al.
N Engl J Med. 2021 Sep 23;385(13):1184-1195. doi: 10.1056/NEJMoa2109682. Epub 2021 Aug 4.
N Engl J Med. 2021.
PMID: 34347950
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite